Cargando…
Organic Nanodelivery Systems as a New Platform in the Management of Breast Cancer: A Comprehensive Review from Preclinical to Clinical Studies
Breast cancer accounts for approximately 25% of cancer cases and 16.5% of cancer deaths in women, and the World Health Organization predicts that the number of new cases will increase by almost 70% over the next two decades, mainly due to an ageing population. Effective diagnostic and treatment stra...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10095028/ https://www.ncbi.nlm.nih.gov/pubmed/37048731 http://dx.doi.org/10.3390/jcm12072648 |
_version_ | 1785023982851850240 |
---|---|
author | Rafik, Salma T. Vaidya, Jayant S. MacRobert, Alexander J. Yaghini, Elnaz |
author_facet | Rafik, Salma T. Vaidya, Jayant S. MacRobert, Alexander J. Yaghini, Elnaz |
author_sort | Rafik, Salma T. |
collection | PubMed |
description | Breast cancer accounts for approximately 25% of cancer cases and 16.5% of cancer deaths in women, and the World Health Organization predicts that the number of new cases will increase by almost 70% over the next two decades, mainly due to an ageing population. Effective diagnostic and treatment strategies are, therefore, urgently required for improving cure rates among patients since current therapeutic modalities have many limitations and side effects. Nanomedicine is evolving as a promising approach for cancer management, including breast cancer, and various types of organic and inorganic nanomaterials have been investigated for their role in breast cancer diagnosis and treatment. Following an overview on breast cancer characteristics and pathogenesis and challenges of the current treatment strategies, the therapeutic potential of biocompatible organic-based nanoparticles such as liposomes and polymeric micelles that have been tested in breast cancer models are reviewed. The efficacies of different drug delivery and targeting strategies are documented, ranging from synthetic to cell-derived nanoformulations together with a summary of the interaction of nanoparticles with externally applied energy such as radiotherapy. The clinical translation of nanoformulations for breast cancer treatment is summarized including those undergoing clinical trials. |
format | Online Article Text |
id | pubmed-10095028 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-100950282023-04-13 Organic Nanodelivery Systems as a New Platform in the Management of Breast Cancer: A Comprehensive Review from Preclinical to Clinical Studies Rafik, Salma T. Vaidya, Jayant S. MacRobert, Alexander J. Yaghini, Elnaz J Clin Med Review Breast cancer accounts for approximately 25% of cancer cases and 16.5% of cancer deaths in women, and the World Health Organization predicts that the number of new cases will increase by almost 70% over the next two decades, mainly due to an ageing population. Effective diagnostic and treatment strategies are, therefore, urgently required for improving cure rates among patients since current therapeutic modalities have many limitations and side effects. Nanomedicine is evolving as a promising approach for cancer management, including breast cancer, and various types of organic and inorganic nanomaterials have been investigated for their role in breast cancer diagnosis and treatment. Following an overview on breast cancer characteristics and pathogenesis and challenges of the current treatment strategies, the therapeutic potential of biocompatible organic-based nanoparticles such as liposomes and polymeric micelles that have been tested in breast cancer models are reviewed. The efficacies of different drug delivery and targeting strategies are documented, ranging from synthetic to cell-derived nanoformulations together with a summary of the interaction of nanoparticles with externally applied energy such as radiotherapy. The clinical translation of nanoformulations for breast cancer treatment is summarized including those undergoing clinical trials. MDPI 2023-04-02 /pmc/articles/PMC10095028/ /pubmed/37048731 http://dx.doi.org/10.3390/jcm12072648 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Rafik, Salma T. Vaidya, Jayant S. MacRobert, Alexander J. Yaghini, Elnaz Organic Nanodelivery Systems as a New Platform in the Management of Breast Cancer: A Comprehensive Review from Preclinical to Clinical Studies |
title | Organic Nanodelivery Systems as a New Platform in the Management of Breast Cancer: A Comprehensive Review from Preclinical to Clinical Studies |
title_full | Organic Nanodelivery Systems as a New Platform in the Management of Breast Cancer: A Comprehensive Review from Preclinical to Clinical Studies |
title_fullStr | Organic Nanodelivery Systems as a New Platform in the Management of Breast Cancer: A Comprehensive Review from Preclinical to Clinical Studies |
title_full_unstemmed | Organic Nanodelivery Systems as a New Platform in the Management of Breast Cancer: A Comprehensive Review from Preclinical to Clinical Studies |
title_short | Organic Nanodelivery Systems as a New Platform in the Management of Breast Cancer: A Comprehensive Review from Preclinical to Clinical Studies |
title_sort | organic nanodelivery systems as a new platform in the management of breast cancer: a comprehensive review from preclinical to clinical studies |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10095028/ https://www.ncbi.nlm.nih.gov/pubmed/37048731 http://dx.doi.org/10.3390/jcm12072648 |
work_keys_str_mv | AT rafiksalmat organicnanodeliverysystemsasanewplatforminthemanagementofbreastcanceracomprehensivereviewfrompreclinicaltoclinicalstudies AT vaidyajayants organicnanodeliverysystemsasanewplatforminthemanagementofbreastcanceracomprehensivereviewfrompreclinicaltoclinicalstudies AT macrobertalexanderj organicnanodeliverysystemsasanewplatforminthemanagementofbreastcanceracomprehensivereviewfrompreclinicaltoclinicalstudies AT yaghinielnaz organicnanodeliverysystemsasanewplatforminthemanagementofbreastcanceracomprehensivereviewfrompreclinicaltoclinicalstudies |